Search

everythinglearnresearchcommunity

for

Search:↓

The compound (1R,2S)-4-(2-Cyano-cyclohexyl-oxy)-2-trifluoromethyl-benzonitrile can stimulate hair growth and reduce oil production when applied topically.

Controlled delivery of specific RNA and IL-4 restored hair growth in mice with autoimmune alopecia.

Two drugs, ritlecitinib and brepocitinib, improved scalp hair loss condition markers.

Topical calcitriol is safe for preventing hair loss during chemotherapy.

CGF therapy may effectively treat psoriasis by reducing inflammation.

The oral contraceptive alone is the preferred treatment for hirsutism, as adding the GnRH analog showed no significant benefit.

Anti-TNF therapy can cause hair loss and skin issues.

Acitretin effectively improved the woman's skin condition.

SOCS3 treatment can prevent hair loss by stopping harmful immune responses.

Oral baricitinib and ruxolitinib are effective and safe for treating alopecia areata.

Adding celecoxib to chemotherapy improves survival and quality of life for gastric cancer patients with positive COX-2.

A man with Cronkhite-Canada syndrome improved significantly with immunosuppressive therapy.

Targeted immunological therapies offer safer and more effective treatments for skin conditions like eczema and psoriasis.

Biologics for severe asthma have known side effects, but some new risks need more study.

Clobetasol and pimecrolimus are similarly effective for alopecia areata, but pimecrolimus has fewer side effects and is preferred for long-term use.

Simvastatin/ezetimibe may help treat new cases of alopecia areata but not long-term cases.

Immunotherapy with pembrolizumab significantly reduced cancer in a young woman with adrenocortical carcinoma.

Ritlecitinib improves emotional well-being and activity levels in alopecia areata patients.

Collaborative care between physicians and pharmacists improved medication management for rheumatoid arthritis without raising costs.

Cetuximab can cause excessive eyelash growth.

Oral tacrolimus helped a rheumatoid arthritis patient regrow hair lost due to alopecia areata.

The document concludes that side effects from Smoothened inhibitor drugs for skin cancer are reversible and can be managed with a team approach to maintain quality of life.

The committee decided not to approve the drug due to low effectiveness and high risks.

Ritlecitinib shows promise as a versatile treatment for various autoimmune and inflammatory diseases.

Ritlecitinib effectively treats severe Alopecia Areata by reducing harmful immune activity in the skin.

Cyproterone acetate is effective for treating hirsutism, but some patients may feel worse on low-dose maintenance therapy.

Tofacitinib may be effective for treating hair loss caused by alopecia areata that doesn't respond to other treatments.

JAK inhibitors effectively treat severe atopic dermatitis and alopecia areata.

JAK inhibitors are more effective and safer for treating alopecia areata than dupilumab and apremilast.

A patient with PPP had rare skin reactions to adalimumab, which improved after stopping smoking and continuing acitretin.